Drug Information

Drug General Information
Drug ID
D01ZUN
Former ID
DNC009202
Drug Name
3,3-di(pent-4-enyl)azetidin-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529529]
Formula
C13H21NO
Canonical SMILES
C=CCCCC1(CNC1=O)CCCC=C
InChI
1S/C13H21NO/c1-3-5-7-9-13(10-8-6-4-2)11-14-12(13)15/h3-4H,1-2,5-11H2,(H,14,15)
InChIKey
RZYCKKZEBQDDLK-UHFFFAOYSA-N
PubChem Compound ID
44560664
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529529]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.